Status:

RECRUITING

Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)

Lead Sponsor:

Nemours Children's Clinic

Conditions:

Polycystic Ovarian Syndrome in Adolescent Females

Obesity (Disorder)

Eligibility:

FEMALE

12-18 years

Brief Summary

The prevalence of childhood obesity in the United States has more than tripled in the past four decades affecting one in every five adolescent girls and is disproportionally higher among racial and/or...

Detailed Description

The prevalence of childhood obesity in the United States has more than tripled in the past four decades affecting one in every five adolescent girls and is disproportionally higher among racial and/or...

Eligibility Criteria

Inclusion

  • Diagnosed with PCOS, by NIH criteria: oligomenorrhea (menstrual cycles \<21 or \>35 days) and hyperandrogenism (testosterone level or free androgen index (FAI) \> refence range for tanner stage) and in good overall health
  • Obesity (equal to or more than the 95th percentile)
  • Females ages 12 to 18 years, at least 2 years post-menarche
  • Participants has persistent symptoms of PCOS and obesity despite lifestyle modifications for at least 4 months.

Exclusion

  • Has abnormal thyroid function tests at Screening.
  • Has suspected or known Diabetes mellitus, impaired fasting glucose, or elevated hemoglobin A1c.
  • Has non-classic congenital adrenal hyperplasia.
  • Has hyperprolactinemia.
  • Has a known history or family history of medullary thyroid carcinoma or MEN2 and history of pancreatitis
  • Participants receiving prior treatment with metformin, GLP-1 agonists, oral contraception pills, progesterone, or other insulin sensitizers for at least 6 weeks prior to Screening.
  • Is currently pregnant or has been pregnant.

Key Trial Info

Start Date :

September 11 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT07169136

Start Date

September 11 2025

End Date

December 1 2026

Last Update

September 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Nemours Children's Clinic

Jacksonville, Florida, United States, 32207